Diabetes and Cancer Research Consortium
A consortium to look into the connection between diabetes therapy
and cancer was formed in 2010.
- Consortium statement, February 2010
- Steering committee:
- Edwin Gale, Bristol, UK
- Andrew Renahan, Manchester, UK
- Bendix Carstensen,
Copenhagen, Denmark
- Sarah Wild, Edinburgh, UK
- Jeff Johnson, Edmonton, Canada
- Soffia Gudbjörnsdottir, Gothenburg, Sweden
- EASD has appointed Edwin Gale, Andrew Renahan and Bendix Carstensen
to a task force to advise EASD
on the topic. The DCRC is one of the activities of the task
force.
Bendix Carstensen is not member of the task force as of 1 June 2011.
The task force has submitted
a note to the
EASD in relation to the Banff meeting (see below).
- The Consortium has regular meetings:
- Papers:
It has been decided (in Banff, March 2011) to formulate position
papers to clarify and quantify the links between diabetes and cancer
in particular the relative timing of these events.
(These links are currently dead)
Last updated: 4 August 2011, BxC